Abstract SARS-CoV-2’s remarkable resistance to nucleotide analog antivirals such as remdesivir , which thwarts RNA synthesis by inhibiting viral polymerase (RdRp), challenges available therapies . We reveal that remdesivir incorporation destabilizes RdRp–RNA complex while enhancing RNA binding to the proofreading exoribonuclease (ExoN), facilitating remdesivir excision. Conserved ExoN determinants for remdesivir recognition and excision underpin ExoN-mediated resistance across all coronaviruses . These findings inform the design of next-generation antivirals and combination therapies capable of overcoming ExoN-mediated resistance. Source: Proceedings of the National Academy of Sciences of the United States of America, https://www.pnas.org/doi/full/10.1073/pnas.2519755122 ____
Media Monitoring for Signals about Emerging Threats